An investigation of MRSA infection in a hospice
Autor: | Petra Flock, Simone Ali, Nigel Sykes, Emma Hall, Janet Buchan |
---|---|
Rok vydání: | 2005 |
Předmět: |
Adult
Male Staphylococcus aureus medicine.medical_specialty Palliative care Meticillin medicine.drug_class Antibiotics medicine.disease_cause 03 medical and health sciences 0302 clinical medicine 030502 gerontology Internal medicine Intensive care medicine Humans Infection control Intensive care medicine Aged Antibacterial agent Aged 80 and over Cross Infection Infection Control business.industry Hospices General Medicine Middle Aged Staphylococcal Infections biochemical phenomena metabolism and nutrition bacterial infections and mycoses Methicillin-resistant Staphylococcus aureus Anesthesiology and Pain Medicine Carriage 030220 oncology & carcinogenesis Female Methicillin Resistance 0305 other medical science business medicine.drug |
Zdroj: | Palliative Medicine. 19:188-196 |
ISSN: | 1477-030X 0269-2163 |
DOI: | 10.1191/0269216305pm1011oa |
Popis: | This study investigated the prevalence of methicillin-resistant Staphylococcus aureus (MRSA) carriage and infection among patients admitted to a hospice. Under the existing policy at this hospice, only patients admitted from hospital wards where MRSA is known to be present are screened for MRSA prior to transfer. Hence the investigators were keen to study patients transferred from settings other than this. One hundred and twenty patients, all either from the community or from hospital wards without known MRSA, were entered into the study (‘study group’) and were swabbed for MRSA on admission to the hospice. Swabbing was continued at weekly intervals until discharge or death. Of the 120 patients, seven (5.8%) were MRSA positive on admission. A further four patients who were negative on admission showed MRSA on later swabs. Another two patients developed symptomatic infections during admission that were proven to be due to MRSA, but neither of these had shown MRSA on any swabs taken during the study. During the study period, a separate group of 156 patients was swabbed routinely before transfer from hospital wards where MRSA was known to be present in accordance with hospice policy (‘non-study group’). Of these patients, 11 (7.1%) were found to be colonized with MRSA but none developed associated symptomatic infection. It appears that the risk of symptomatic infection with MRSA in hospice patients is low, and the burden placed on this vulnerable group by conventional eradication regimes may be disproportionate to any benefit derived. |
Databáze: | OpenAIRE |
Externí odkaz: |